Clinical trial
Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With…
NCT00392340 · Children's Cancer and Leukaemia Group, Other · Unknown status
Key facts
| NCT number | NCT00392340 |
|---|---|
| Title | Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma |
| Official title | An Open-Label, Multicentre, Phase II Study of TVD as Treatment for Children With Stage 4 Neuroblastoma Failing to Respond to First-Line Treatment According to HR-NBL-01/ E-SIOP [Topotecan-Vincristine-Doxorubicin in Children With Stage 4 Neuroblastoma Failing to Respond to COJEC (TVD)] |
| Lead sponsor | Children's Cancer and Leukaemia Group, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, doxorubicin hydrochloride, topotecan hydrochloride, vincristine sulfate |
| Enrollment | 63 |
| Start date | Mar 1, 2008 |
| Primary completion | Jan 1, 2010 |
| First posted | Oct 26, 2006 |
| Last update posted | Sep 17, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: